Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9ARF7
Term | Name | Level | Count |
---|---|---|---|
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006778 | porphyrin-containing compound metabolic process | 5 | 1 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 6 | 1 |
GO:0006783 | heme biosynthetic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0033013 | tetrapyrrole metabolic process | 4 | 1 |
GO:0033014 | tetrapyrrole biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042168 | heme metabolic process | 3 | 1 |
GO:0042440 | pigment metabolic process | 2 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0046148 | pigment biosynthetic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008767 | UDP-galactopyranose mutase activity | 4 | 7 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016853 | isomerase activity | 2 | 7 |
GO:0016866 | intramolecular transferase activity | 3 | 7 |
GO:0004729 | oxygen-dependent protoporphyrinogen oxidase activity | 5 | 1 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 1 |
GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 4 | 1 |
GO:0070818 | protoporphyrinogen oxidase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.460 |
CLV_PCSK_PC1ET2_1 | 193 | 195 | PF00082 | 0.460 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 236 | 240 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.292 |
DEG_APCC_DBOX_1 | 50 | 58 | PF00400 | 0.188 |
DEG_APCC_KENBOX_2 | 186 | 190 | PF00400 | 0.266 |
DEG_SPOP_SBC_1 | 302 | 306 | PF00917 | 0.378 |
DOC_ANK_TNKS_1 | 142 | 149 | PF00023 | 0.378 |
DOC_MAPK_FxFP_2 | 205 | 208 | PF00069 | 0.335 |
DOC_MAPK_gen_1 | 185 | 192 | PF00069 | 0.447 |
DOC_MAPK_gen_1 | 404 | 411 | PF00069 | 0.493 |
DOC_MAPK_MEF2A_6 | 160 | 168 | PF00069 | 0.408 |
DOC_MAPK_RevD_3 | 179 | 194 | PF00069 | 0.402 |
DOC_PP2B_LxvP_1 | 289 | 292 | PF13499 | 0.363 |
DOC_PP4_FxxP_1 | 153 | 156 | PF00568 | 0.335 |
DOC_PP4_FxxP_1 | 205 | 208 | PF00568 | 0.335 |
DOC_USP7_MATH_1 | 259 | 263 | PF00917 | 0.439 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.447 |
DOC_USP7_UBL2_3 | 218 | 222 | PF12436 | 0.419 |
DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.281 |
LIG_14-3-3_CanoR_1 | 126 | 134 | PF00244 | 0.404 |
LIG_14-3-3_CanoR_1 | 484 | 488 | PF00244 | 0.571 |
LIG_Actin_WH2_2 | 368 | 386 | PF00022 | 0.466 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.550 |
LIG_BRCT_BRCA1_1 | 141 | 145 | PF00533 | 0.438 |
LIG_CSL_BTD_1 | 94 | 97 | PF09270 | 0.408 |
LIG_deltaCOP1_diTrp_1 | 195 | 205 | PF00928 | 0.335 |
LIG_deltaCOP1_diTrp_1 | 86 | 95 | PF00928 | 0.359 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.329 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.354 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.447 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.447 |
LIG_FHA_1 | 304 | 310 | PF00498 | 0.335 |
LIG_FHA_1 | 383 | 389 | PF00498 | 0.479 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.363 |
LIG_FHA_2 | 372 | 378 | PF00498 | 0.382 |
LIG_FHA_2 | 463 | 469 | PF00498 | 0.514 |
LIG_IRF3_LxIS_1 | 72 | 78 | PF10401 | 0.480 |
LIG_LIR_Apic_2 | 204 | 208 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 254 | 265 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 323 | 334 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 352 | 361 | PF02991 | 0.364 |
LIG_LIR_Gen_1 | 397 | 407 | PF02991 | 0.512 |
LIG_LIR_Gen_1 | 64 | 73 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 78 | 86 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 254 | 260 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 323 | 329 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 340 | 345 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 352 | 358 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 397 | 402 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 427 | 432 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 64 | 69 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 78 | 83 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.308 |
LIG_MAD2 | 6 | 14 | PF02301 | 0.385 |
LIG_PCNA_yPIPBox_3 | 422 | 436 | PF02747 | 0.232 |
LIG_SH2_CRK | 257 | 261 | PF00017 | 0.355 |
LIG_SH2_NCK_1 | 442 | 446 | PF00017 | 0.456 |
LIG_SH2_STAP1 | 257 | 261 | PF00017 | 0.335 |
LIG_SH2_STAT3 | 98 | 101 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 328 | 331 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.335 |
LIG_SH3_3 | 467 | 473 | PF00018 | 0.468 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.320 |
LIG_SUMO_SIM_anti_2 | 385 | 390 | PF11976 | 0.285 |
LIG_SUMO_SIM_par_1 | 356 | 362 | PF11976 | 0.335 |
LIG_SUMO_SIM_par_1 | 368 | 374 | PF11976 | 0.335 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.429 |
LIG_TYR_ITIM | 255 | 260 | PF00017 | 0.335 |
LIG_TYR_ITIM | 365 | 370 | PF00017 | 0.402 |
LIG_UBA3_1 | 308 | 314 | PF00899 | 0.480 |
MOD_CDC14_SPxK_1 | 287 | 290 | PF00782 | 0.188 |
MOD_CDK_SPxK_1 | 284 | 290 | PF00069 | 0.188 |
MOD_CK1_1 | 210 | 216 | PF00069 | 0.416 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.320 |
MOD_CK2_1 | 371 | 377 | PF00069 | 0.375 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.634 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.434 |
MOD_GlcNHglycan | 284 | 287 | PF01048 | 0.468 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.416 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.471 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.454 |
MOD_GSK3_1 | 462 | 469 | PF00069 | 0.482 |
MOD_GSK3_1 | 483 | 490 | PF00069 | 0.574 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.480 |
MOD_N-GLC_1 | 201 | 206 | PF02516 | 0.344 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.348 |
MOD_NEK2_1 | 301 | 306 | PF00069 | 0.335 |
MOD_NEK2_1 | 359 | 364 | PF00069 | 0.480 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.351 |
MOD_NEK2_1 | 483 | 488 | PF00069 | 0.546 |
MOD_NEK2_2 | 201 | 206 | PF00069 | 0.335 |
MOD_NEK2_2 | 337 | 342 | PF00069 | 0.335 |
MOD_PIKK_1 | 359 | 365 | PF00454 | 0.438 |
MOD_PIKK_1 | 475 | 481 | PF00454 | 0.447 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.477 |
MOD_PKA_2 | 337 | 343 | PF00069 | 0.335 |
MOD_PKA_2 | 483 | 489 | PF00069 | 0.575 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.335 |
MOD_Plk_1 | 201 | 207 | PF00069 | 0.335 |
MOD_Plk_1 | 447 | 453 | PF00069 | 0.361 |
MOD_Plk_1 | 466 | 472 | PF00069 | 0.455 |
MOD_Plk_2-3 | 253 | 259 | PF00069 | 0.378 |
MOD_Plk_2-3 | 371 | 377 | PF00069 | 0.289 |
MOD_Plk_4 | 337 | 343 | PF00069 | 0.335 |
MOD_Plk_4 | 371 | 377 | PF00069 | 0.347 |
MOD_Plk_4 | 447 | 453 | PF00069 | 0.360 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.335 |
MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.281 |
MOD_SUMO_rev_2 | 2 | 8 | PF00179 | 0.493 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.355 |
TRG_ENDOCYTIC_2 | 257 | 260 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 367 | 370 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.335 |
TRG_ER_diArg_1 | 292 | 295 | PF00400 | 0.476 |
TRG_ER_diArg_1 | 434 | 437 | PF00400 | 0.375 |
TRG_NES_CRM1_1 | 378 | 393 | PF08389 | 0.394 |
TRG_Pf-PMV_PEXEL_1 | 295 | 299 | PF00026 | 0.480 |
TRG_Pf-PMV_PEXEL_1 | 45 | 49 | PF00026 | 0.188 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0X8 | Leptomonas seymouri | 74% | 100% |
A0A0S4J0D0 | Bodo saltans | 53% | 100% |
A0A1X0P6P6 | Trypanosomatidae | 57% | 100% |
A0A3S5H724 | Leishmania donovani | 95% | 100% |
A0A422NWN4 | Trypanosoma rangeli | 59% | 100% |
A4H9C5 | Leishmania braziliensis | 86% | 100% |
A4HXP6 | Leishmania infantum | 95% | 100% |
Q5EEK0 | Leishmania major | 93% | 100% |
V5BLY6 | Trypanosoma cruzi | 58% | 100% |